Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 2/20 | 0.77 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.77 |
| ▸ | KCNK5 | O95279 | 1/20 | 0.77 |
| ▸ | KCNK17 | Q96T54 | 1/20 | 0.77 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.77 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 2/20 | 0.45 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.43 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.43 |
| ▸ | DGAT2 | Q96PD7 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL498641 | 0.87 | KCNA5 (1.00) | KCNA5KCNK3KCNK5KCNK17KCNK9 | |
| SCHEMBL4234451 | 0.83 | KCNA5 (0.79) | KCNA5KCNK3KCNK5KCNK17KCNK9 | |
| SCHEMBL4234905 | 0.83 | KCNA5 (0.78) | KCNA5KCNK3KCNK5KCNK17KCNK9 | |
| SCHEMBL12434045 | 0.82 | KCNA5 (0.78) | KCNA5KCNK3KCNK5KCNK17KCNK9 | |
| SCHEMBL4231221 | 0.81 | KCNA5 (0.85) | KCNA5KCNK3KCNK5KCNK17KCNK9 | |
| SCHEMBL4231667 | 0.80 | KCNA5 (0.79) | KCNA5KCNK3KCNK5KCNK17KCNK9 | |
| SCHEMBL5697876 | 0.79 | KCNA5 (0.52) | KCNA5KCNK3KCNK5KCNK17KCNK9 | |
| SCHEMBL12434336 | 0.79 | KCNA5 (0.84) | KCNA5KCNK3KCNK5KCNK17KCNK9 | |
| SCHEMBL5697841 | 0.79 | KCNA5 (0.53) | KCNA5KCNK3KCNK5KCNK17KCNK9 | |
| SCHEMBL5697868 | 0.79 | KCNA5 (0.76) | KCNA5KCNK3KCNK5KCNK17KCNK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4658919-B2 | — | — | 2011-03-23 | — | — | JP | claimed |
| EP-1720549-A1 | KV1.5-BLOCKER FOR THE SELECTIVE INCREASE OF ATRIAL CONTRACTILITY AND TREATMENT OF CARDIAC INSUFFICIENCY | Sanofi-Aventis Deutschland GmbH (DE) | 2006-11-15 | — | — | EP | claimed |
| JP-2006520342-A | — | — | 2006-09-07 | — | — | JP | claimed |
| EP-1670551-A1 | COMBINATION OF PHENYLCARBOXAMIDES WITH BETA-ADRENERGIC RECEPTOR BLOCKERS AND USE THEREOF FOR THE TREATMENT OF ATRIAL ARRHYTHMIAS | Sanofi-Aventis Deutschland GmbH (DE) | 2006-06-21 | — | — | EP | claimed |
| EP-1605976-A1 | PHENYLCARBOXYL ACID AMIDES AND IK r CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA | Sanofi-Aventis Deutschland GmbH (DE) | 2005-12-21 | — | — | EP | claimed |
| WO-2005084675-A1 | KV1.5-BLOCKER FOR THE SELECTIVE INCREASE OF ATRIAL CONTRACTILITY AND TREATMENT OF CARDIAC INSUFFICIENCY | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2005-09-15 | — | — | WO | claimed |
| WO-2005025674-A1 | COMBINATION OF PHENYLCARBOXAMIDES WITH BETA-ADRENERGIC RECEPTOR BLOCKERS AND USE THEREOF FOR THE TREATMENT OF ATRIAL ARRHYTHMIAS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2005-03-24 | — | — | WO | claimed |
| WO-2004082716-A1 | PHENYLCARBOXYL ACID AMIDES AND IKr CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2004-09-30 | — | — | WO | claimed |
| EP-1720549-A1 | KV1.5-BLOCKER FOR THE SELECTIVE INCREASE OF ATRIAL CONTRACTILITY AND TREATMENT OF CARDIAC INSUFFICIENCY | Sanofi-Aventis Deutschland GmbH (DE) | 2006-11-15 | — | — | EP | disclosed |
| EP-1222163-B1 | 2'-SUBSTITUTED 1,1'-BIPHENYL-2-CARBONAMIDES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS A MEDICAMENT AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2006-07-12 | — | — | EP | disclosed |
| EP-1670551-A1 | COMBINATION OF PHENYLCARBOXAMIDES WITH BETA-ADRENERGIC RECEPTOR BLOCKERS AND USE THEREOF FOR THE TREATMENT OF ATRIAL ARRHYTHMIAS | Sanofi-Aventis Deutschland GmbH (DE) | 2006-06-21 | — | — | EP | disclosed |
| EP-1605976-A1 | PHENYLCARBOXYL ACID AMIDES AND IK r CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA | Sanofi-Aventis Deutschland GmbH (DE) | 2005-12-21 | — | — | EP | disclosed |
| WO-2005084675-A1 | KV1.5-BLOCKER FOR THE SELECTIVE INCREASE OF ATRIAL CONTRACTILITY AND TREATMENT OF CARDIAC INSUFFICIENCY | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2005-09-15 | — | — | WO | disclosed |
| WO-2005025674-A1 | COMBINATION OF PHENYLCARBOXAMIDES WITH BETA-ADRENERGIC RECEPTOR BLOCKERS AND USE THEREOF FOR THE TREATMENT OF ATRIAL ARRHYTHMIAS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2005-03-24 | — | — | WO | disclosed |
| WO-2004082716-A1 | PHENYLCARBOXYL ACID AMIDES AND IKr CHANNEL INHIBITORS COMBINATION AND THE USE THEREOF FOR TREATING ATRIAL ARRHYTHMIA | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2004-09-30 | — | — | WO | disclosed |
| EP-1222163-A1 | 2'-SUBSTITUTED 1,1'-BIPHENYL-2-CARBONAMIDES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS A MEDICAMENT AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS | Aventis Pharma Deutschland GmbH (DE) | 2002-07-17 | — | — | EP | disclosed |
| WO-2001025189-A1 | 2'-SUBSTITUTED 1,1'-BIPHENYL-2-CARBONAMIDES, METHOD FOR THE PRODUCTION THEREOF, USE THEREOF AS A MEDICAMENT AND PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-04-12 | — | — | WO | disclosed |